Safety of daclizumab: 3-year results from the SELECTED study
Multiple Sclerosis Research,
The paper: Gold, Ralf, et al. "Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from…
The paper: Gold, Ralf, et al. "Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from…
Gold R, Radue EW, Giovannoni G, Selmaj K, Havrdova E, Stefoski D, Sprenger T, Montalban X, Cohan S, Umans K, Greenberg SJ, Ozen…